THL

Agiliti Announces Closing of Acquisition by THL

Retrieved on: 
星期二, 五月 7, 2024

Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. (“THL”).

Key Points: 
  • Agiliti Inc. (NYSE: AGTI) (“Agiliti”), a nationwide provider of medical technology management and service solutions to the healthcare industry, today announced the closing of its acquisition by an affiliate of private equity firm Thomas H. Lee Partners, L.P. (“THL”).
  • On February 26, 2024, Agiliti announced that THL had signed a definitive agreement to purchase all outstanding shares of Agiliti common stock not currently owned by THL and its affiliates or certain management and director shareholders for $10.00 per share, implying a total enterprise value of $2.5 billion.
  • “The work we do at Agiliti has strengthened our nation’s healthcare system for more than 85 years,” said Tom Leonard, CEO of Agiliti.
  • Centerview Partners LLC acted as exclusive financial advisor to the Special Committee of the Board of Directors of Agiliti (the “Special Committee”).

AGILITI ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of AGTI and Encourages Investors to Contact the Firm

Retrieved on: 
星期四, 四月 25, 2024

Click here to learn more and participate in the action.

Key Points: 
  • Click here to learn more and participate in the action.
  • On February 26, 2024, Agiliti announced that it had entered into an agreement to be acquired by THL in a $2.5 billion cash deal.
  • Bragar Eagel & Squire is concerned that Agiliti’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Agiliti’s stockholders.

AGILITI ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of HRT and Encourages Investors to Contact the Firm

Retrieved on: 
星期四, 四月 18, 2024

Click here to learn more and participate in the action.

Key Points: 
  • Click here to learn more and participate in the action.
  • On February 26, 2024, Agiliti announced that it had entered into an agreement to be acquired by THL in a $2.5 billion cash deal.
  • Bragar Eagel & Squire is concerned that Agiliti’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Agiliti’s stockholders.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN)

Retrieved on: 
星期一, 四月 1, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the agreement, AdTheorent will be acquired by Cadent, LLC (“Cadent”).
  • The Company’s common stockholders will receive cash consideration of $3.21 per share.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq - FUSN), Kinnate Biopharma Inc. (Nasdaq – KNTE)

Retrieved on: 
星期一, 三月 25, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Under the terms of the Merger Agreement, Agiliti will be acquired by Thomas H. Lee Partners, L.P. (“THL”).
  • Under the terms of the agreement, Landos Biopharma will be acquired by AbbVie Inc. (“AbbVie”) (NYSE - ABBV).
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Agiliti, Inc. (NYSE – AGTI)

Retrieved on: 
星期二, 三月 19, 2024

The investigation concerns whether the Agiliti Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.

Key Points: 
  • The investigation concerns whether the Agiliti Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration offers fair value to the Company’s shareholders.
  • You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at [email protected] , visit https://www.brodskysmith.com/cases/agiliti-inc-nyse-agti/ , or call toll free 855-576-4847.
  • Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits.
  • The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders.

Agiliti, Inc. (AGTI) Shareholder Alert: Robbins LLP Informs Stockholders it is Investigating the Acquisition of Agiliti Inc. by THL Partners

Retrieved on: 
星期二, 三月 12, 2024

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Agiliti, Inc. (NYSE: AGTI) by private equity firm Thomas H. Lee Partners, L.P. ("THL").

Key Points: 
  • SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Agiliti, Inc. (NYSE: AGTI) by private equity firm Thomas H. Lee Partners, L.P. ("THL").
  • Under the terms of the agreement, Agiliti stockholders will receive $10.00 in cash for each share of Agiliti common stock owned.
  • Is the Proposed Acquisition Best for Agiliti, Inc. (AGTI) and its Shareholders?
  • On February 26, 2024, Agiliti announced a deal to be acquired by THL.

Robbins LLP Reminds Investors That It Is Investigating the Acquisition of AGTI

Retrieved on: 
星期二, 三月 26, 2024

Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Agiliti, Inc. (NYSE: AGTI) by private equity firm Thomas H. Lee Partners, L.P. ("THL").

Key Points: 
  • Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Agiliti, Inc. (NYSE: AGTI) by private equity firm Thomas H. Lee Partners, L.P. ("THL").
  • Under the terms of the agreement, Agiliti stockholders will receive $10.00 in cash for each share of Agiliti common stock owned.
  • Is the Proposed Acquisition Best for Agiliti, Inc. (AGTI) and its Shareholders?
  • Robbins LLP is concerned that Agiliti's board of directors engaged in an unfair process and agreed to an unfair amount to be paid to shareholders.

AGTI Investor Notice: Robbins LLP Reminds Shareholders it is Investigating the Acquisition of Agiliti Inc. by THL Partners

Retrieved on: 
星期一, 三月 18, 2024

Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Agiliti, Inc. (NYSE: AGTI) by private equity firm Thomas H. Lee Partners, L.P. ("THL").

Key Points: 
  • Shareholder rights law firm Robbins LLP informs investors it is investigating the acquisition of Agiliti, Inc. (NYSE: AGTI) by private equity firm Thomas H. Lee Partners, L.P. ("THL").
  • Under the terms of the agreement, Agiliti stockholders will receive $10.00 in cash for each share of Agiliti common stock owned.
  • Is the Proposed Acquisition Best for Agiliti, Inc. (AGTI) and its Shareholders?
  • Robbins LLP is concerned that Agiliti's board of directors engaged in an unfair process and agreed to an unfair amount to be paid to shareholders.

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), L.S. Starrett Company (NYSE - SCX), Equitrans Midstream Corporation (NYSE - ETRN), Sterling Check Corp. (Nasdaq – STER)

Retrieved on: 
星期一, 三月 11, 2024

If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.

Key Points: 
  • If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
  • Starrett will be acquired by an affiliate of MiddleGround Capital (“MiddleGround”) in an all-cash transaction for $16.19 per share.
  • Under the terms of the Merger Agreement, Equitrans will be acquired by EQT Corporation (“EQT”) (NYSE - EQT) in an all-stock transaction.
  • Sterling shareholders will elect to receive either $16.73 in cash or 0.979 shares of First Advantage common stock for each Sterling share.